Uh-oh! This study is no longer available.
Non-small Cell Lung Cancer – Stage 3
PMG Research of DuPage Medical Group
18 or older
A research study is evaluating an investigational anti-cancer medication combination for locally advanced, unresectable, stage 3 non-small cell lung cancer.
This research study may be an option if you:
• Have a diagnosis of locally advanced, unresectable stage 3 non-small cell lung cancer
• Have a body weight of at least 77lbs
• Have no history of autoimmune or inflammatory disorders (including
• inflammatory bowel disease [eg, colitis or Crohn's disease], diverticulitis [with the exception of diverticulosis], systemic lupus erythematosus, Sarcoidosis syndrome, or Wegener syndrome, granulomatosis with polyangiitis, Graves' disease, rheumatoid arthritis, hypophysitis, uveitis)
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
Qualified participants will receive all study-related care and study medications at no cost.
Patient Commitment Duration
Approximately 5 years
Financial compensation may be provided for time and travel expenses.
Number of visits in study
Approximately 52 clinic visits